Hepatic mitochondrial function control of high-fat diet-induced weight gain

肝线粒体功能控制高脂饮食引起的体重增加

基本信息

  • 批准号:
    10450906
  • 负责人:
  • 金额:
    $ 7.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-08 至 2023-03-07
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Obesity is the strongest independent predictor for the onset and progression of metabolic diseases, such as type 2 diabetes and cardiovascular disease. Weight gain occurs due to a shift to a positive energy balance through some combination of increased food/energy intake and decreased total energy expenditure. Energy balance is not constant or consistent, and therefore long-term weight gain occurs as a sum of numerous, small positive fluctuations over time scales ranging from days to seasons. These acute episodes of positive energy balance occur as a complex interaction of the current obesogenic environment and inappropriate metabolic regulation. One route of metabolic regulation may be the control of food/energy intake through a liver/brain axis. The main goal of the proposed 5-year research career development plan is to facilitate the applicant's transition from postdoctoral fellow to a fully independent academic scientist. This will be accomplished by training the applicant in a variety of metabolic, neurophysiology, and molecular techniques that will be used to identify mechanisms by which the hepatic mitochondrial function impacts short-term, western diet- induced weight gain. Reduced liver fatty acid oxidation and lower hepatic energy status results in increased food intake, which requires intact vagal nerve communication between the brain and the liver. Additionally, we have shown that increased food/energy intake, weight gain, and adiposity are associated with decreased hepatic fatty acid oxidation and mitochondrial respiratory capacity during a 3-day high fat diet (HFD). The central hypothesis of this proposal is that reduced hepatic mitochondrial function results in increased acute HFD-induced weight gain via: 1) increased HFD food intake, and 2) decreased hepatic and systemic utilization of fat. In this proposal, we will use a liver-specific, PGC-1α heterozygous (LPGC1a+/-) mouse model to study the role of reduced hepatic mitochondrial respiratory function on HFD-induced weight gain. Hepatic vagotomy will be used to test the involvement of liver/brain afferent signals in LPGC1a+/- and wildtype mice. Additional work will include experiments to study the role of hepatic mitochondrial function in onset of metabolic inflexibility and control of systemic substrate utilization, and the role of liver adenine nucleotide levels in the initiation of hepatic efferent vagal signal.
项目摘要 肥胖是代谢性疾病发生和进展的最强独立预测因子,例如 2糖尿病与心血管疾病。体重增加是由于通过以下方式向正能量平衡转变 食物/能量摄入量增加和总能量消耗减少的某种组合。能量平衡 不是恒定的或一致的,因此长期的体重增加是作为一个众多的,小的积极的总和发生的。 从几天到几个季节的时间尺度上的波动。这些正能量平衡的急性发作 作为当前致胖环境和不适当的代谢调节的复杂相互作用而发生。 代谢调节的一种途径可以是通过肝/脑轴控制食物/能量摄入。主要 拟议的5年研究职业发展计划的目标是促进申请人的过渡 从博士后到完全独立的学术科学家这将通过培训来实现 申请人在各种代谢,神经生理学和分子技术,将用于 确定肝脏线粒体功能影响短期西方饮食的机制- 诱导体重增加。肝脏脂肪酸氧化减少和肝脏能量状态降低导致 食物摄入,这需要大脑和肝脏之间完整的迷走神经通信。另外我们 已经表明,食物/能量摄入增加、体重增加和肥胖与肝细胞减少有关。 在3天高脂饮食(HFD)期间的脂肪酸氧化和线粒体呼吸能力。中央 该建议的假设是,肝线粒体功能降低导致急性HFD诱导的肝细胞凋亡增加。 体重增加通过:1)增加HFD食物摄入,和2)减少脂肪的肝脏和全身利用。在这 我们将使用肝脏特异性的PGC-1α杂合(LPGC 1a +/-)小鼠模型来研究 降低HFD诱导的体重增加的肝线粒体呼吸功能。将使用肝迷走神经切断术 以测试LPGC 1a +/-和野生型小鼠中肝/脑传入信号的参与。其他工作将包括 研究肝线粒体功能在代谢紊乱发作和 全身底物利用和肝腺嘌呤核苷酸水平在肝传出神经起始中的作用 迷走神经信号

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

E Matthew Morris其他文献

High Fat/High Sucrose Diet Consumption Worsens Comorbid Metabolic Outcomes In An Early Life Stress Model Of Urologic Chronic Pelvic Pain In Mice
高脂肪/高蔗糖饮食消耗在小鼠泌尿生殖系统慢性骨盆疼痛的早期生命应激模型中使合并代谢结果恶化
  • DOI:
    10.1016/j.jpain.2023.02.094
  • 发表时间:
    2023-04-01
  • 期刊:
  • 影响因子:
    4.000
  • 作者:
    Jenna Frick;Rebecca M. Foright;Brittni Levasseur;Tara E. McQuillan;Paige M. Minchella;E Matthew Morris;John P. Thyfault;Julie A. Christianson
  • 通讯作者:
    Julie A. Christianson

E Matthew Morris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('E Matthew Morris', 18)}}的其他基金

Kansas Center for Metabolism and Obesity REsearch (KC-MORE) - Project 2
堪萨斯代谢和肥胖研究中心 (KC-MORE) - 项目 2
  • 批准号:
    10598046
  • 财政年份:
    2022
  • 资助金额:
    $ 7.91万
  • 项目类别:
Hepatic mitochondrial function control of high-fat diet-induced weight gain
肝线粒体功能控制高脂饮食引起的体重增加
  • 批准号:
    9751299
  • 财政年份:
    2017
  • 资助金额:
    $ 7.91万
  • 项目类别:
Hepatic mitochondrial function control of high-fat diet-induced weight gain
肝线粒体功能控制高脂饮食引起的体重增加
  • 批准号:
    10242724
  • 财政年份:
    2017
  • 资助金额:
    $ 7.91万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 7.91万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 7.91万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 7.91万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了